Fully oral regimen with decitabine and cedazuridine plus venetoclax: a new step forward for older or unfit patients with acute myeloid leukaemia

Lancet Haematol. 2024 Apr;11(4):e245-e246. doi: 10.1016/S2352-3026(24)00060-7. Epub 2024 Mar 4.

Author

Affiliation

¹ Section of Haematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia (UNIMORE), Modena 41123, Italy. Electronic address: acandoni@unimore.it.

PMID: 38452789
DOI: 10.1016/S2352-3026(24)00060-7

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Azacitidine / therapeutic use
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
Decitabine / therapeutic use
Drug Combinations*
Humans
Leukemia, Myeloid, Acute* / drug therapy
Sulfonamides*

Substances

decitabine and cedazuridine drug combination
venetoclax
Decitabine
Bridged Bicyclo Compounds, Heterocyclic
Azacitidine
Drug Combinations
Sulfonamides